Navigation Links
ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2011 on September 12, 2011
Date:9/6/2011

RANCHO CORDOVA, Calif., Sept. 6, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal fourth quarter and full year ended June 30, 2011, on Monday, September 12, 2011.

Company's Conference Call and Webcast

Management will host a conference call Monday, September 12, 2011 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal fourth quarter and fiscal year end financial results.  

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. J. Melville Engle, Chairman and Chief Executive Officer and Mr. Matthew Plavan, Chief Financial Officer and Executive Vice President, Business Development will host the call to discuss the year end, quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately five minutes before the conference call begins.  

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. (www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release contains forward-looking statements.  These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal years 2011 and 2012, and introduction of competitive products and other factors beyond our control could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2011 and 2012.  A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.
Web site: http://www.thermogenesis.com
Contact: Investor Relations
+1-916-858-5107, or
ir@thermogenesis.com


'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ThermoGenesis Announces China Customer Implements Cord Blood Products
2. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
3. ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line
4. Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009
5. ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
6. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
7. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
8. ThermoGenesis Provides Update on Fiscal 2009 Results
9. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
10. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
11. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- For today, Stock-Callers.com redirects investors, attention to ... clinical research aimed at treating diseases and medical conditions. Under ... Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM ... our complimentary research reports on these stocks now at: ... http://stock-callers.com/registration ...
(Date:4/19/2017)... Portland, OR (PRWEB) , ... April 19, 2017 , ... ... with Panic Disorder , Company Seeks to Leverage Clinical Data in its Upcoming Post ... and formal registration of an 81 patient clinical trial assessing efficacy of its NBTX-001, ...
(Date:4/19/2017)... April 19, 2017  As a Bronze ... Heroin Summit ,  Proove┬« Biosciences, Inc. announces ... environmental, and lifestyle factors to accurately predict prescription ... of Southern California (USC), the Interventional Pain Institute ... publish results showing that Proove Opioid Risk┬« accurately ...
(Date:4/18/2017)... ... April 18, 2017 , ... CallTower, an industry-leading ... Solution Provider. , Channel Partners program recognizes IT and telecom channel leaders who ... advocacy of the channel during transition and convergence. CallTower is the first provider ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):